George W. LeMaitre - Dec 19, 2022 Form 4 Insider Report for LEMAITRE VASCULAR INC (LMAT)

Role
Chairman and CEO, Director, 10%+ Owner
Signature
/s/ Laurie A. Churchill, Attorney-in-fact
Stock symbol
LMAT
Transactions as of
Dec 19, 2022
Transactions value $
$264,006
Form type
4
Date filed
12/21/2022, 07:49 PM
Previous filing
Dec 13, 2022
Next filing
Dec 27, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LMAT Common Stock Options Exercise $0 +63 +0% $0.00 2.5M Dec 19, 2022 Direct F1
transaction LMAT Common Stock Tax liability -$21.8K -477 -0.02% $45.74 2.5M Dec 19, 2022 Direct F2
transaction LMAT Common Stock Options Exercise $0 +29 +0% $0.00 2.5M Dec 20, 2022 Direct F1
transaction LMAT Common Stock Tax liability -$14.5K -312 -0.01% $46.46 2.5M Dec 20, 2022 Direct F3
transaction LMAT Common Stock Options Exercise $300K +12.7K +0.51% $23.56 2.51M Dec 20, 2022 Direct F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LMAT Dividend Equivalent Rights Options Exercise $0 -63 -46.86% $0.00 71.4 Dec 19, 2022 Common Stock 63 Direct F5
transaction LMAT Dividend Equivalent Rights Options Exercise $0 -29 -30.11% $0.00 67.3 Dec 20, 2022 Common Stock 29 Direct F6
transaction LMAT Stock Option (Right to Buy) Options Exercise $0 -12.7K -50% $0.00 12.7K Dec 20, 2022 Common Stock 12.7K $23.56 Direct F7, F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis.
F2 These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of restricted stock units awarded to the reporting person on December 19, 2018. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934.
F3 These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of restricted stock units awarded to the reporting person on December 20, 2019. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934.
F4 Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II.
F5 These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 19, 2018. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F6 These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 20, 2019. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F7 This option is exercisable and vests over a five-year period at a rate of 20% on the first anniversary of the date listed in the table, and the balance vests in equal annual installments over the remaining four years, with the final vesting occurring on the 11th month after the fourth anniversary.
F8 The expiration date of this option to the extent it is an incentive stock option is 12/19/2023, and the expiration date of this option to the extent it is a nonqualified stock option is 12/19/2025.